Prostate Cancer
Anti-angiogenic therapies in prostate cancer - Abstract
November 20, 2012
Partial sampling of radical prostatectomy specimens: Detection of positive margins and extraprostatic extension - Abstract
November 20, 2012
Association of obesity and diabetes with serum prostate-specific antigen levels in Japanese males - Abstract
November 20, 2012
The REDUCE metagram: A comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer - Abstract
November 19, 2012
Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer - Abstract
November 19, 2012
Strength training induces muscle hypertrophy and functional gains in Black prostate cancer patients despite androgen deprivation therapy - Abstract
November 19, 2012
Cabazitaxel: More than a new taxane for metastatic castrate-resistant prostate cancer? - Abstract
November 19, 2012
Management of docetaxel failures in metastatic castrate-resistant prostate cancer - Abstract
November 16, 2012
Targeted therapies in metastatic castration-resistant prostate cancer: Beyond the androgen receptor - Abstract
November 16, 2012
Bone-targeted agents: Preventing skeletal complications in prostate cancer - Abstract
November 16, 2012
Advanced clinical states in prostate cancer - Abstract
November 16, 2012
The experience with cytotoxic chemotherapy in metastatic castration-resistant prostate cancer - Abstract
November 16, 2012
Pathological features of lymph node metastases in predicting biochemical recurrence after radical prostatectomy for prostate cancer - Abstract
November 16, 2012